Jie
Lin
a,
Renlei
Wang
a,
Guohua
Xu
a,
Zhengfeng
Ding
a,
Xueshen
Zhu
a,
Xingzhong
Liu
b,
Jian
Zou
c,
Guodong
Chen
c,
Li
Li
d and
Ling
Liu
*b
aJiangsu Key Laboratory for Biofunctional Molecules, College of Life Science and Chemistry, Jiangsu Second Normal University, 77 West Beijing Road, Nanjing 210013, P. R. China
bState Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, P. R. China. E-mail: liul@im.ac.cn.; Tel: +86 10 64806153
cInstitute of Traditional Chinese Medicine & Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, P. R. China
dInstitute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, P. R. China
First published on 24th November 2016
Five new cadinane sesquiterpenoids, pholiotins A–E (1–5), and three known compounds, 11-hydroxy-1(10)-valencen-2-one (6), 8,11-dihydroxy-1(10)-eremophilen-2-one (7) and durgamone (8), were isolated from the crude extract of Pholiota sp. Their structures were established on the basis of extensive spectroscopic analysis. Their absolute configurations were determined by X-ray diffraction, the Snatzke's method and electronic circular dichroism (ECD) calculations. All isolates were tested for antifungal activity.
| Pos. | 1 | 2 | 3 | |||
|---|---|---|---|---|---|---|
| δ C a | δ H b (J in Hz) | δ C a | δ H b (J in Hz) | δ C a | δ H b (J in Hz) | |
| a Recorded at 125 MHz. b Recorded at 500 MHz. | ||||||
| 1 | 42.1, CH | 1.80, m | 43.0, CH | 1.80, m | 43.0, CH | 1.80, m |
| 2a | 22.4, CH2 | 2.24, m | 22.2, CH2 | 2.25, m | 22.3, CH2 | 2.24, m |
| 2b | 1.28, m | 1.28, m | 1.28, m | |||
| 3a | 26.4, CH2 | 2.47, m | 26.3, CH2 | 2.47, m | 26.4, CH2 | 2.50, m |
| 3b | 2.18, m | 2.18, m | 2.18, m | |||
| 4 | 131.7, qC | 131.9, qC | 131.7, qC | |||
| 5 | 140.6, CH | 7.07, s | 140.3, CH | 7.10, s | 140.4, CH | 7.11, s |
| 6 | 40.2, CH | 2.04, m | 40.4, CH | 2.04, m | 40.4, CH | 2.04, m |
| 7 | 39.5, CH | 1.66, m | 40.1, CH | 1.66, m | 40.1, CH | 1.66, m |
| 8a | 28.4, CH2 | 1.83, m | 26.6, CH2 | 1.81, m | 28.5, CH2 | 1.81, m |
| 8b | 1.52, m | 1.52, m | 1.52, m | |||
| 9 | 69.5, CH | 4.07, br s | 73.1, CH | 5.37, br s | 69.5, CH | 4.02, br s |
| 10 | 74.9, qC | 74.2, qC | 73.7, qC | |||
| 11 | 168.7, qC | 168.5, qC | 168.5, qC | |||
| 12 | 26.5, CH | 2.12, m | 26.5, CH | 2.12, m | 26.5, CH | 2.12, m |
| 13 | 21.5, CH3 | 0.92, d (6.9) | 21.5, CH3 | 0.95, d (6.9) | 21.5, CH3 | 0.97, d (6.9) |
| 14 | 15.4, CH3 | 0.82, d (6.9) | 15.2, CH3 | 0.87, d (6.9) | 15.4, CH3 | 0.88, d (6.9) |
| 15a | 62.8, CH2 | 3.63, br s | 63.1, CH2 | 3.71, d (12) | 62.8, CH2 | 4.22, d (12) |
| 15b | 3.65, d (12) | 4.16, d (12) | ||||
| 16 | 171.0, qC | |||||
| 17 | 20.8, CH3 | 2.15, s | ||||
| 18 | 170.9, qC | |||||
| 19 | 21.2, CH3 | 2.12, s | ||||
The absolute configuration of 1 was initially assigned by application of the modified Mosher method.21,22 Treatment of 1 with (S)- and (R)-MTPACl afforded the (R)-MTPA ester 1a and the (S)-MTPA esters 1b, respectively. The selectivity for the acylation of C-9 hydroxy group was not achieved, but the ester 1a acylation of C-15 hydroxy group was obtained by reversed-phase HPLC purification. The absolute configuration of the sec/tert-9,10-diol moiety in 1a was assigned using the in situ dimolybdenum CD method developed by Frelek.23,24 Upon addition of dimolybdenum tetraacetate [Mo2(OAc)4] to 1a in DMSO solution, a metal complex of chiral vic-diol with the achiral Mo2(OAc)4 was generated as an auxiliary chromophore. Since 1a has an inherent CD resulting from the C-11 carboxylic chromophore, this contribution was subtracted to give the induced CD of the metal complex to avoid its overlap (>250 nm) with those generated after addition of Mo2(OAc)4. Therefore, the observed sign of the Cotton effect in the induced spectrum originates solely from the chirality of the vic-diol moiety expressed by the sign of the O–C–C–O torsion angle. The positive Cotton effects observed at around 310 and 400 nm, respectively, in the induced CD spectrum permitted assignment of the 9S and 10S absolute configuration in 1a on the basis of the empirical rule proposed by Snatzke (Fig. 4 and 5). The absolute configuration of 9,10-diol moiety in 1 was deduced as 9S and 10S by analogy to 1a. Considering the relative configuration established by single-crystal X-ray crystallographic, 1 was assigned the 1S,6S,7R,9S, and 10S.
The absolute configuration of 1 was further confirmed by comparison of the experimental and the simulated circular dichroism (CD) spectra (Fig. 6) generated by the time-dependent density functional theory (TDDFT).25 Compound 1 was used to calculate two enantiomers, (1S,6S,7R,9S,10S)-1 (1c) and (1R,6R,7S,9R,10R)-1 (1d). MMFF94 conformational search and DFT re-optimization at the B3LYP/6-31+G(d) level yielded 6 lowest energy conformers for 1c (Fig. S25†). The overall calculated ECD spectra of 1c and 1d were then generated by Boltzmann weighting of the conformers (Fig. 6). The experimental ECD curve of 1 was nearly identical to the calculated ECD spectrum of 1c, suggested the 1S,6S,7R,9S,10S absolute configuration for 1, which was consistent with the result deduced from the Snatzke's method.
![]() | ||
| Fig. 6 Experimental ECD spectrum of 1 in MeOH and the calculated ECD spectra of 1c and 1d, after a UV correction of 10 nm. | ||
The molecular formula of pholiotin B (2) was determined to be C17H26O6 (five degrees of unsaturation) by HRESIMS, 42 mass units higher than that of 1. Analysis of the NMR spectroscopic data (Table 1) of 2 revealed nearly identical structural features to those found in 1, except that the oxymethine proton signal (H-9) was shifted downfield (δH 4.07 in 1 vs. 5.37 in 2). In addition, NMR resonances corresponding to an acetyl group (δH 2.12; δC 21.2 and 170.9) were observed, indicating that the C-9 oxygen of 2 was acylated, which was confirmed by an HMBC correlation from H-9 to the carboxylic carbon (δC 170.9) of the acetyl group. Therefore, 2 was determined as the C-9 monoacetate of 1 and its relative configuration was deduced by analogy to 1. The CD spectra of 1 and 2 (Fig. S20 and S21; ESI†) both showed positive Cotton effects at 220 nm, and negative Cotton effects at 249 nm, indicating that the absolute configuration of 2 was the same as that of 1.
Pholiotin C (3) was assigned the same molecular formula C17H26O6 as 2 by HRESIMS. Interpretation of the NMR data (Table 1) of 3 showed similar resonances to those of 2, indicating that 3 is also a monoacetate of 1 but with a different position for acetylation. Specifically, the oxymethene proton signals of H2-15 in 3 (δH 4.16, 4.22) were significantly downfield compared to 1 (δH 3.63), suggesting that OH-15 was acetylated, which was supported by an HMBC correlation from H2-15 to the carboxylic carbon of the acetyl unit (δC 171.0). On the basis of these data, 3 was determined as the C-15 monoacetate of 1. The relative and absolute configurations of 3 were deduced as shown by analogy to 1, which was further confirmed by comparison of its CD data with those of 1 (Fig. S20 and S22; ESI†).
Pholiotin D (4) gave a pseudomolecular ion [M + Na]+ peak, consistent with a molecular formula of C19H28O7 (6 degrees of unsaturation). Analysis of the 1H and 13C NMR data of 4 (Table 2) revealed that 4 is a diacetate of 1. The esterification shifts (Δ = 1.19 ppm for H-9, Δ = 0.62/0.57 ppm for H2-15) were observed, which allowed the acetyl groups to locate at C-9 and C-15, respectively. On the basis of these data, 4 was determined as the C-9 and C-15 diacetate of 1. This observation was supported by relevant HMBC correlations from H-9 to C-18 (δC 171.4) and from H2-15 to C-16 (δC 171.1). The relative and absolute configurations of 4 were deduced as shown by analogy to 1, which was further confirmed by comparison of its CD data with those of 1 (Fig. S20 and S23; ESI†).
| Pos. | 4 | 5 | ||
|---|---|---|---|---|
| δ C a | δ H b (J in Hz) | δ C a | δ H b (J in Hz) | |
| a Recorded at 125 MHz. b Recorded at 500 MHz. | ||||
| 1 | 41.6, CH | 1.83, m | 46.4, CH | 1.97, dt (12, 3.2) |
| 2a | 21.3, CH2 | 2.24, m | 34.1, CH2 | 2.28, m |
| 2b | 1.26, m | 1.49, m | ||
| 3a | 25.4, CH2 | 2.49, m | 25.5, CH2 | 2.53, dd (18, 4.6) |
| 3b | 2.18, m | 2.01, m | ||
| 4 | 131.1, qC | 131.6, qC | ||
| 5 | 139.2, CH | 7.11, s | 140.0, qC | 7.16, s |
| 6 | 39.4, CH | 2.04, m | 40.3, CH | 2.42, dt (10, 1.2) |
| 7 | 39.3, CH | 1.59, m | 38.4, CH | 1.80, m |
| 8a | 25.7, CH2 | 1.86, m | 26.7, CH2 | 1.90, dt (12, 3.3) |
| 8b | 1.46, m | 1.36, dt (3.0, 13) | ||
| 9 | 72.1, CH | 5.26, br s | 72.9, CH | 4.40, br s |
| 10 | 73.6, qC | 155.1, qC | ||
| 11 | 169.9, qC | 168.5, qC | ||
| 12 | 25.6, CH | 2.13, m | 25.5, CH | 2.28, m |
| 13 | 20.6, CH3 | 0.95, d (6.9) | 21.5, CH3 | 0.98, d (6.9) |
| 14 | 14.4, CH3 | 0.89, d (6.9) | 15.3, CH3 | 0.82, d (6.9) |
| 15a | 64.7, CH2 | 4.25, d (12) | 106.0, CH2 | 4.88, s |
| 15b | 4.21, d (12) | 4.66, s | ||
| 16 | 171.1, qC | |||
| 17 | 21.1, CH3 | 2.15, s | ||
| 18 | 171.4, qC | |||
| 19 | 21.4, CH3 | 2.12, s | ||
The elemental composition of pholiotin E (5) was established as C15H22O3 (five degrees of unsaturation) by HRESIMS. Analysis of the 1H and 13C NMR data (Table 2) of 5 revealed almost identical with those found of 1, except that the sp3 quaternary carbon (δC 74.9) and the oxymethylene (δH 3.63; δC 62.8) were replaced by the exocyclic olefin C-10/C-15 (δH 4.66 and 4.88; δC 106.0 and 155.1, respectively), which was confirmed by HMBC cross-peaks from H-6 to C-10, H-9 to C-15, and from H2-15 to C-1, C-9, and C-10. Therefore, the structure of 5 was determined and the relative configuration was confirmed by X-ray crystallography (Fig. 3).
The absolute configuration of 5 was deduced by comparison of the experimental and the simulated circular dichroism (CD) spectra (Fig. 7) generated by the time-dependent density functional theory (TDDFT).25 Compound 5 was used to calculate two enantiomers, (1R,6R,7S,9R)-5 (5a) and (1S,6S,7R,9S)-5 (5b). MMFF94 conformational search and DFT re-optimization at the B3LYP/6-31+G(d) level yielded 4 lowest energy conformers for 5a (Fig. S26†). The overall calculated ECD spectra of 5a and 5b were then generated by Boltzmann weighting of the conformers (Fig. 7). The experimental ECD curve of 5 was nearly identical to the calculated ECD spectrum of 5b, suggested the 1S,6S,7R,9S absolute configuration for 5.
![]() | ||
| Fig. 7 Experimental ECD spectrum of 5 in MeOH and the calculated ECD spectra of 5a and 5b, after a UV correction of 10 nm. | ||
The known compounds 6–8 isolated from the crude extract were identified as 11-hydroxy-1(10)-valencen-2-one (6),17 8,11-dihydroxy-1(10)-eremophilen-2-one (7)18 and durgamone (8),19,20 respectively, by comparison of their NMR and MS data with those reported.
Compounds 1–8 were tested for antifungal activity of Aspergillus flavus (CGMCC 3.0951), Fusarium nivale (CGMCC 3.4600) and Piricularia oryzae (CGMCC 3.3283). Compound 4 showed antifungal effects against Aspergillus flavus (CGMCC 3.0951), with an IC50 value 25.1 µM, while the positive control amphotericin B showed an IC50 value of 3.3 µM. Other compounds proved to be inactive in antifungal assays even at 200 µg mL−1.
:
1 CH2Cl2–MeOH. The resulting subfractions were combined and further purified by RP HPLC (Agilent Zorbax SB-C18 column; 5 µm; 9.4 × 250 mm; 42% MeOH in H2O for 5 min, followed by 45–100% for 30 min; 2 mL min−1) to afford 1 (5.2 mg, tR 17.32 min) and 4 (2.0 mg, tR 26.21 min). The fraction (32 mg) eluted with 60% EtOAc was also separated by RP HPLC (60% MeOH in H2O for 5 min, followed by 80–90% for 25 min) to afford 5 (2.1 mg, tR 15.23 min). The fraction (98 mg) eluted with 65% EtOAc was also separated by RP HPLC (50% MeOH in H2O for 5 min, followed by 80–90% for 35 min) to afford 6 (3.2 mg, tR 17.28 min), 7 (2.8 mg, tR 28.20 min) and 8 (1.5 mg, tR 20.30 min). The fraction (90 mg) eluted with 70% EtOAc was purified by RP HPLC (42% MeOH in H2O for 5 min, followed by 45–100% for 30 min) to afford 2 (4.5 mg, tR 18.94 min) and 3 (3.6 mg, tR 21.12 min).
ε) 212 (3.39), 227 (3.40) nm; CD (c 1.0 × 10−3 M, MeOH) λmax (Δε) 220 (+2.7), 249 (−1.9); IR (neat) νmax 3334, 2953, 1710, 1640, 1408, 1278, 1069, 1040 cm−1; 1H and 13C NMR data see Table 1; HMBC data (acetone-d6, 500 MHz) H-1 → C-2, 3, 6, 7, 10, 15; H2-2 → C-1, 3, 4, 6; H-3b → C-11; H-5 → C-1, 3, 4, 7, 11; H-6 → C-2, 4, 8, 12; H-7 → C-8; H2-8 → C-6, 10, 12; H-12 → C-7, 8, 13, 14; H3-13 → C-7, 12, 14; H3-14 → C-7, 12, 13; H2-15 → C-1, 9, 10; HREIMS m/z 307.1513 (calcd for C15H24O5Na 307.1516).
:
1) using the vapor diffusion method, colorless crystals were obtained for 1, a crystal (0.23 × 0.14 × 0.12 mm) was separated from the sample and mounted on a glass fiber, and data were collected using a Rigaku RAPID IP diffractometer with graphite-monochromated Mo Kα radiation, λ = 0.71073 Å at 173(2) K. Crystal data: C15H14O5, M = 284.34, space group orthorhombic, P2(1)2(1)2(1); unit cell dimensions a = 5.5709 (11) Å, b = 15.994(3) Å, c = 16.547(3) Å, V = 1474.4(5) Å3, Z = 4, Dcalcd = 1.281 mg m−3, µ = 0.095 mm−1, F(000) = 616. The structure was solved by direct methods using SHELXL-977 (ref. 29) and refined by using full-matrix least-squares difference Fourier techniques. All non-hydrogen atoms were refined with anisotropic displacement parameters and all hydrogen atoms were placed in idealized positions and refined as riding atoms with the relative isotropic parameters. Absorption corrections were performed using the Siemens Area Detector Absorption Program (SADABS).30 The 13
237 measurements yielded 1947 independent reflections after equivalent data were averaged, and Lorentz and polarization corrections were applied. The final refinement gave R1 = 0.0450 and wR2 = 0.1089 [I > 2σ(I)].
:
1.3 diol/Mo2(OAc)4 for 1a was subjected to CD measurements at a concentration of 1.0 mg mL−1. The first CD spectrum was recorded immediately after mixing, and its time evolution was monitored until stationary (about 10 min after mixing). The inherent CD was subtracted. The observed signs of the diagnostic bands at around 310 and 400 nm in the induced CD spectrum were correlated to the absolute configuration of the 9,10-diol moiety.
ε) 216 (3.39), 220 (3.38) nm; CD (c 1.0 × 10−3 M, MeOH) λmax (Δε) 222 (+2.2), 249 (−0.8); IR (neat) νmax 3413, 2957, 1692, 1641, 1371, 1243, 1039 cm−1; 1H and 13C NMR data see Table 1; HMBC data (acetone-d6, 500 MHz) H-1 → C-2, 3, 6, 9; H2-2 → C-1, 3, 6; H2-3 → C-1, 2, 4, 5; H-5 → C-1, 3, 7, 11; H-6 → C-1, 2, 4, 8, 12; H-7 → C-6, 8; H2-8 → C-6, 7, 12; H-9 → C-1, 7, 10, 18; H-12 → C-7, 13, 14; H3-13 → C-7, 12, 14; H3-14 → C-7, 12, 13; H2-15 → C-1, 9, 10; H3-19 → C-18; HRESIMS m/z 349.1619 (calcd for C17H26O6Na, 349.1622).
ε) 216 (3.55), 220 (3.62) nm; CD (c 1.3 × 10−3 M, MeOH) λmax (Δε) 219 (+2.7), 250 (−0.8); IR (neat) νmax 3422, 2956, 1690, 1641, 1371, 1241, 1040 cm−1; 1H and 13C NMR data see Table 1; HMBC data (acetone-d6, 500 MHz) H-1 → C-3, 15; H-2a → C-1, 6; H-2b →C-1, 3; H2-3 → C-1, 2, 4, 5; H-5 → C-3, 4, 6, 7, 11; H-7 → C-8; H2-8 → C-6, 10; H-9 → C-7; H-12 → C-7, 13, 14; H3-13 → C-7, 12, 14; H3-14 → C-7, 12, 13; H2-15 → C-1, 9, 10, 16; H3-17 → C-16; HREIMS m/z 349.1623 (calcd for C17H26O6Na 349.1622).
ε) 212 (3.14), 220 (3.13) nm; CD (c 0.8 × 10−3 M, MeOH) λmax (Δε) 218 (+0.5), 259 (−0.2); IR (neat) νmax 3440, 2931, 1719, 1372, 1239, 1037 cm−1; 1H and 13C NMR data see Table 1; HMBC data (acetone-d6, 500 MHz) H-1 → C-3, 15; H2-2 → C-6; H2-3 → C-1; H-5 → C-1, 11; H-6 → C-2; H-7 → C-8; H2-8 → C-6, 10, 12; H-9 → C-1, 7, 10, 18; H-12 → C-7, 13, 14; H3-13 → C-7, 12, 14; H3-14 → C-7, 12, 13; H2-15 → C- 9, 16; H3-17 → C-16; H3-19 → C-18; HRESIMS m/z 391.1728 (calcd for C19H28O7Na, 391.1727).
ε) 214 (3.94) nm; CD (c 1.0 × 10−3 M, MeOH) λmax (Δε) 217 (−20); IR (neat) νmax 3322, 2950, 2921, 2624, 1689, 1643, 1390, 1259, 1057 cm−1; 1H and 13C NMR data see Table 1; HMBC data (acetone-d6, 500 MHz) H2-2 → C-4; H2-3 → C-1, 5; H-5 → C-1, 3, 11; H-6 → C-2, 10; H-7 → C-1; H-9 → C-1, 7, 15; H-12 → C-7, 13, 14; H3-13 → C-7, 12, 14; H3-14 → C-7, 12, 13; H2-15 → C-1, 9, 10; HRESIMS m/z 249.1498 (calcd for C15H21O3, 249.1496).
:
1) using the vapor diffusion method, colorless crystals were obtained for 5, a crystal (0.20 × 0.15 × 0.10 mm) was separated from the sample and mounted on a glass fiber, and data were collected using a Rigaku RAPID IP diffractometer with graphite-monochromated Mo Kα radiation, λ = 0.71073 Å at 173(2) K. Crystal data: C30H46O7, M = 518.67, space group orthorhombic, P2(1)2(1)2; unit cell dimensions a = 16.315 (3) Å, b = 17.050 (3) Å, c = 5.2386 (10) Å, V = 1457.3 (5) Å3, Z = 2, Dcalcd = 1.182 mg m−3, µ = 0.083 mm−1, F(000) = 564. The structure was solved by direct methods using SHELXL-97 (ref. 29) and refined by using full-matrix least-squares difference Fourier techniques. All non-hydrogen atoms were refined with anisotropic displacement parameters and all hydrogen atoms were placed in idealized positions and refined as riding atoms with the relative isotropic parameters. Absorption corrections were performed using the Siemens Area Detector Absorption Program (SADABS).30 The 12
011 measurements yielded 1929 independent reflections after equivalent data were averaged, and Lorentz and polarization corrections were applied. The final refinement gave R1 = 0.0430 and wR2 = 0.1026 [I > 2σ(I)].
Footnote |
| † Electronic supplementary information (ESI) available: Experimental procedures, NMR spectra of compounds 1–5. CCDC 861573 and 861574. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6ra22448b |
| This journal is © The Royal Society of Chemistry 2016 |